Radiation-induced bowel damage occurred in 4.3% of patients treated primarily by irradiation for uterine carcinoma during the period 1962-1982. There has been a progressive rise in the incidence of radiation damage and radiation-induced rectovaginal fistula during this 20-year period. Radiation from intracavitary sources was a contributory factor in 92% of injured cases. The rising incidence of bowel damage in our patients may be due to an increase in the number of patients receiving a high rectal dose from the intracavitary source. There was a significantly (P<0.01) higher incidence of radiation injury in cases of cervical carcinoma compared to endometrial carcinoma. This was because cervical carcinoma tended to present at a more advanced stage than endometrial carcinoma and was more frequently treated with combined external and intracavitary irradiation. There was no significant increase in the incidence of complications among patients undergoing hysterectomy.
Introduction
The success of radium treatment in the control of uterine cancer became obvious' soon after its intro-duction2 in 1900. Subsequently, improvement in disease control and in survivaleven in advanced diseasehas been achieved by the development of a combination of external beam irradiation of the pelvic lymphatics plus intracavitary radioactive implantation at the site of the primary lesion3. However, within 15 years of the first use of radium, radiation-induced rectal stricture and fistula had been recognized4 as a dose-related complication.
Precautions have been introduced in the last 20 years which aim to reduce the irradiation of normal adjacent tissue. These include improved fractionation of radiation exposure5, shielding of midline pelvic structures3, 'afterloading' which allows the position of the intracavitary source to be screened prior to irradiation6, and the monitoring of rectal radiation dose. However, as there is no central registry of radiation-induced complications in the UK, the overall effect of developments, both in the management of uterine cancer and in precautions against injury, on the incidence of radiation-induced bowel damage is unknown7. This paper describes the change in the incidence of this complication during the last 20 years in a centre which treats about 100' new cases of uterine cancer a year.
Patients and methods
During the 20-year period from 1963, 1801 patients with either endometrial or cervical carcinoma were treated with irradiation for primary disease. There has been a slight but progressive decline from 104 new cases per year in 1963 to 81 new cases per year in 1982. The proportion of cases of cervical carcinoma compared to endometrial carcinoma has decreased from 1.6:1 in the five-year period 1963-1968 to 1.1:1 in the five-year period 1978-1983. There has been no significant change, during this 20-year period, in the distribution of stage of disease at presentation for either cervical or endometrial carcinoma. Case notes and details of treatment and follow up were obtained in 79% (1418) of cases; this was the patient group studied. Patients whose details were not available were distributed evenly throughout the 20-year period so this did not bias the results.
Radiation treatment regimens
Fourteen percent (197) of patients received whole pelvis external beam irradiation from a 60Co source, or a 5 or 8 MeV linear accelerator. The majority (78%) of these patients received 4000-4500 cGy over a 4-week period.
Forty-nine percent (694) were treated by intracavitary radiation, using radium (1963) (1964) (1965) (1966) (1967) (1968) (1969) (1970) or caesium (after 1970), in accordance with the Manchester technique8. Since 1977 the Curietron Caesium low-dose rate afterloading apparatus has been used9. Twenty-four percent (340) of patients received doses ranging between 6600 and 7000 cGy to point A (Caesium sources) or 7000-7500 Roentgen to point A (Radium sources) given in two insertions separated by one week. A further 25% (354) of patients received 3300-80 cGy to point A in one or two insertions over a maximum of 2 weeks.
Thirty-seven percent (527) of patients received combined external beam and intracavitary radiation. Patients who had already been treated with two intracavitary insertions and were thought to have received a maximum tolerance dose to the rectum, received external radiation via split pelvic fields (before 1970) or parallel opposed fields with a central parametrial wedge to shield the midline (after 1970). The dose from split pelvic field external beam radiation was 3000-3500 cGy midplane dose in 3-4 weeks. The total dose from the parametrial wedge external beam radiation and intracavitary radiation was 5000 cGy to point B over 3 weeks. Where only one intracavitary insertion had been performed, and the patient was thought to have received less than the maximum tolerance dose to the rectum, whole pelvis irradiation (4000-4250 cGy) was used.
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Pattern of bowel involvement
The pattern of radiation-induced bowel complications is shown in Table 3 . The interval between the end of radiotherapy and detection of injury was less for radiation-induced rectovaginal fistula (13 months median, range 2 months-7 years) than for rectal stricture (24 months median, range 6 weeks-li years). Ileal stricture occurred in 4 patients: all had received external beam radiation (in 2 cases combined with intracavitary radiation) and 3 had undergone hysterectomy prior to radiotherapy.
Discussion
Despite the relatively low (4.3%) incidence of radiation-induced bowel injury, there has been a small but progressive rise (Figure 2 ) in the overall incidence of radiation-induced damage and rectovaginal fistula at The London Hospital during the last 20 years. Follow up is shorter for those irradiated in the last 5-year period than the preceding 15 years, so this rise may be expected to become more marked as a few more recently irradiated patients develop late bowel complications.
It is not possible to identify the reason for this increase from this retrospective review of patients treated in a variety of ways, but there may be some clues. Most (95%) radiation-induced bowel complications involved the rectum or sigmoid colon (Table  3) , and intracavitary radiation was used in 92% of all cases sustaining radiation injury. There was a wide distribution of rectal dosage in those patients in whom rectal radiation from the intracavitary sources was measured; in 3% of cases it was 6000 cGy or more (Figure 1) . Thus it appears that rectal irradiation from the intracavitary sources was difficult to control; it is known'0 that a small (7%) increase in intracavitary dose can produce a large (x 7) increase in the incidence of rectal ulceration. The rising incidence of bowel damage in our patients may be due to an increase in the number of patients receiving a high rectal dose from the intracavitary source.
There have been three changes during the period under review which could have contributed to this: (1) a significant trend, in more recent years, for a greater proportion of patients to receive intracavitary radiation than in the earlier years of the study; (2) a change in 1970 from radium to caesium intracavitary sources associated with a change from measuring dosage in roentgens (exposure) to rads (absorbed dose). Although a conversion factor was used to allow for the change in units, these changes may have resulted in a change in radiobiological effect; (3) the introduction of afterloading in 1977. The measurement of rectal radiation dose is not included in the afterloading technique. Although the source may be in a good position on preliminary screening, a change in position as the patient moves, resulting in an increased rectal dose, is not apparent. There was a significantly greater risk of radiation injury in cases of cervical carcinoma than endometrial carcinoma. However, this increased risk was due to the tendency for cervical carcinoma to present at a more advanced stage than endometrial carcinoma; thus a higher proportion of patients with cervical carcinoma required combined intracavitary and external beam irradiation, which was associated with a higher rate of radiation injury. It has been suggested that hysterectomy prior to radiotherapy results in an increased incidence of radiationinduced complications11. In the present study, the only increase was in the small number of patients with ileal damage, where there was an increase in the incidence of radiation damage among hysterectomy patients (0.4%) compared to those who had not undergone hysterectomy (0.2%). Terminal ileal injury occurred less frequenty (0.3%) than has previously been reported (0.5-5%) in a review of this complication'2 and it was invariably associated with treatment by external beam irradiation.
Despite the introduction of precautions to prevent radiation-induced bowel injury, the incidence appears to have increased in our hospital over the last 20 years. An increase in the incidence of radiation injury may not be obvious from the perspective of day-to-day clinical practice, because the number of affected cases in one centre is small. Varied techniques of treatment in different hospitals may result in differing levels (2.-30.4%) of radiation-induced bowel injury"3"4 which compare favourably with that reported here. The trend towards an increased incidence, which we have noted, might also be present in other hospitals, but as information about radiation-induced injury is not registered this can not be determined. The impact of developments in treatment planning and the difference between centres in treatment techniques could be evaluated if a national register of therapeutic radiation-injury was compiled.
